Ligand validation:5ZLH

MNH: MANGANESE PROTOPORPHYRIN IX

MNH is a Ligand Of Interest in 5ZLH designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5ZLH_MNH_C_500	41%	5%	0.203	0.918	2.59	2.65	14	11	2	0	100%	1
5ZLH_MNH_A_500	40%	5%	0.203	0.916	2.61	2.71	14	10	9	0	100%	1
5ZLH_MNH_B_500	26%	5%	0.247	0.889	2.62	2.71	14	11	6	0	100%	1
5ZLH_MNH_D_500	25%	5%	0.252	0.889	2.57	2.64	13	9	5	0	100%	1
7WG0_MNH_A_502	92%	8%	0.089	0.98	2.35	2.34	13	14	1	0	100%	1
5ZIS_MNH_B_500	57%	5%	0.187	0.965	2.62	2.71	14	11	4	0	100%	1
6JZS_MNH_C_504	97%	7%	0.073	0.987	2.22	2.55	12	12	0	0	100%	1
2O5Q_MNH_X_154	89%	5%	0.086	0.964	3.07	2.35	11	11	0	0	100%	1
6DS8_MNH_A_202	79%	1%	0.127	0.973	1.59	5.61	5	19	0	0	100%	1
4IT2_MNH_B_201	77%	9%	0.131	0.971	2.07	2.35	8	14	0	0	100%	0.98
2O5B_MNH_X_154	77%	2%	0.119	0.957	3.72	3.02	13	13	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.